GF8 – Vilnius, June 2007 Hugh Whittall Director Nuffield Council on Bioethics Establishing and supporting research ethics infrastructure and networking.

Slides:



Advertisements
Similar presentations
Global Forum on Bioethics in Research – nearing 10 years of dialogue
Advertisements

Global Forum on Bioethics in Research Sandra Realpe (GFBR-Secretariat) Carel IJsselmuiden (COHRED, Director) The 8th Global Forum -
The European Commission as a Partner of International Cooperation in Research Ethics Governance and Ethics Unit Directorate-General for Research European.
Global Forum on Bioethics in Research First Meeting for the Eastern Mediterranean and Arab Forum on Bioethics in Research Cairo, Egypt. 12 – 14 August.
Vilnius, 29 June 2007 CIOMS Recommendations on Ethics in Medical Research The Eighth Global Forum on Bioethics in Research Gottfried Kreutz Dr. med., Dipl.-Chem.;
Dr. Marie-Charlotte Bouësseau Ethics, Trade, Human Rights and Health Law Role of WHO in establishing and supporting Research Ethics Committees Global Forum.
Ethical standards in biomedical research: the acquis and projects of the Council of Europe Laurence Lwoff Bioethics Division Council of Europe
Group 1.3 Relationships between RECs in multi-centre, international studies –problems and solutions.
STUDENTS PERSPECTIVE ON TRAINING PROGRAMS Joanna Rozynska GSSR, Institute of Philosophy and Sociology Polish Academy of Science 8th Global Forum of Bioethics,
E. GefenasGlobal Forum 8, June, 2007, Vilnius Regional Perspective to Keynote Challenges - Europe.
Measuring health outcomes of engagement in the arts: the Arts Health Strategy for the Australia Council.
Elements for Integrating Early Warning into Disaster Preparedness and Management Policies A Contribution of the EWC-II Advisory Group to the High level.
EPAA Conference 5 November 2007 Georgette LALIS Enterprise and Industry DG European Commission The international dimension of regulatory acceptance.
4 th Meeting of the EC International Dialogue on Bioethics Copenhagen, June 19 th, 2012 Large research and medical databases in clinical and research multi-centred.
Respect for participants Dr Enoka Corea. maintaining the privacy of the participant by ensuring confidentiality ensuring that participants may withdraw.
Post Research Benefits Mandika Wijeyaratne MS, MD, FRCS Dept. of Surgery, Colombo.
Protecting and promoting the interests of patients and the public in health research 1 MHRA / LRMN event The UK regulatory landscape in 2013 New GTAC arrangements.
Ethics Approval for Projects based overseas George Ellison (Director) Research & Graduate School
The Oviedo Convention from the Perspective of DG Research Dr. Lino PAULA European Commission DG Research, Governance and Ethics Unit.
BIOETHICS: THE SUBJECT, PURPOSE AND OBJECTIVES OF THE HEALTH CARE SYSTEM. BIOETHICS OF BIOMEDICAL EXPERIMENTS. INTERNATIONAL DOCUMENTS ON BIOETHICS AND.
Research Governance in Practice
Good Participatory Practice (GPP) Guidelines for Biomedical HIV Prevention Trials Second Edition 2011.
CITY OF BRISTOL ISOLATION TO INCLUSION (I2I) ACTION PLAN.
Responsible Sponsorship A case study Dr Birgit Whitman, Head of Research Governance.
Genetics and insurance in the UK
LIMITLESS POTENTIAL | LIMITLESS OPPORTUNITIES | LIMITLESS IMPACT Copyright University of Reading IMPACT AND THE LIFE SCIENCES Anthony Atkin (Research Impact.
What’s in a name? Identifying multiple representations of women who provide eggs for mitochondrial research. Erica Haimes and Ken Taylor PEALS Research.
Putting the UN Disability Convention into practice Sara Brunet, Senior Lawyer and UNCRPD lead officer, EHRC.
UNESCO´s activities in Bioethics National Bioethics Committees
Presidency of Council of Ministers National Committee for Biosafety, Biotechnology and Life Sciences (D.P.C.M. March 19, 2007)
The Forensic Use of Bioinformation: ethical issues Professor Sir Bob Hepple QC FBA Chairman, Nuffield Council on Bioethics and Working Group.
Horizon 2020 The EU Framework Programme for Research and Innovation Health, Demographic Change and Wellbeing Lul Raka, NCP for Horizon 2020 – Health.
Genetic advances will only be acceptable if their application is carried out ethically, with due regard to autonomy, justice, education and the beliefs.
Clinical Research in South Africa - Ethical and Regulatory Processes NATIONAL HEALTH RESEARCH ETHICS COUNCIL Professor A Dhai Deputy Chair National Health.
Collection and use of human biological specimens in research: Is there adequate ethics governance in Africa? Madison T. Little and Francis H. Barchi, PhD.
NHS | Presentation to [XXXX Company] | [Type Date]1 Senates - the interface with SCNs and AHSNs Nigel Acheson Medical Director NHS England (South)
The work of the Research Ethics Committee Dr Carol Chu.
Wessex LETB The Changing Landscape Paul Holmes, Managing Director.
Developing a National Critical Care Clinical Research Network: what’s in it for trainees? Paul Dark Associate Professor, Faculty of Medical and Human Sciences,
Mary Manning, Executive Director. Getting started The Academy of Medical Sciences: who we are Getting started on policy work Governance Selecting topics.
Patient Information Forum (PiF) Overview.
R&D – a perspective Dr Nana Theodorou Research Coordinator Sheffield Clinical Research Office.
What happens when the research is over? Researcher and funder perspectives J Whitworth Head of International Activities Wellcome Trust Global Forum on.
Biologics and Genetic Therapies Directorate Health Products and Food Branch HEALTH CANADA Helping Canadians maintain and improve their health. Agnes Klein.
Royal Irish Academy Briefing Bert Rima 109/01/2016.
Accessing the NHS for Research – NHS R&D Permissions Jemma Hughes R&D Manager ABMU Health Board.
1/28/2016 Prevention Research and Natioanl Aids Plans Geneva 1 Prevention Research and National AIDS Plans June 2005 Geneva, Switzerland Prof. Roy.
Stream A LEGISLATION AND POLICY report back. Main issuess Formal Aspects Experience and lessons learned Plans and visions for the future Actions.
HPTN Ethics Guidance for Research: Community Obligations Africa Regional Working Group Meeting, May 19-23, 2003 Lusaka, Zambia.
Bioethics as a Governance Practice Health Ethics and Law Annual Lecture 2015 Jonathan Montgomery Professor of Health Care Law, UCL Chair, Nuffield Council.
Overcoming challenges in pediatric oncology product development: Regulatory oversight of multi-national clinical studies Ursula Kern, Advisory Committees.
AssessPlanDo Review QuestionYesNo? Do I know what I want to evaluate and why? Consider drivers and audience Do I already know the answer to my evaluation.
Further development of ethics teaching How can UNESCO contribute?
Introduction to Research Governance, Ethics and Integrity Mrs April Lockyer Senior Research Policy Officer (Governance and Integrity)
Health Technology Assessment Methodology, an EUnetHTA View Basics for the Assessment in EU Countries PharmDr. Martin Visnansky, MBA, PhD., MSc. (HTA) HTA.
Genome editing: What lessons can we learn from the mitochondrial donation debate? Peter Thompson Human Fertilisation & Embryology Authority.
European network for Health Technology Assessment | JA | EUnetHTA European network for Health Technology Assessment THL Info.
Slide 1 The contribution of a world-class regulatory environment to the future of the industry in Ireland Pat O’Mahony Chief Executive, Irish Medicines.
Principles 7 Main obstacles articulated in implementing the leading ESF Principles  Uncertainty on advantages  Assumed higher administrative costs 
Dr. Sophia Kisting Director, ILO Programme on HIV and AIDS and the world of work Joint ILO and WHO guidelines on Health Services and HIV/AIDS.
MIT University Skopje Ass. Prof. Oliver Andonov, PhD
Regulation in the NHS and other high risk industries
An elegant solution to a complex problem – the power of partnership
The new Professional Leadership Body: supporting advanced and specialist practice Dr Catherine Duggan.
Assessing the Safety of Stem Cell Therapeutics
AGREEMENT FOR TRANSPARENCY The Case of Mexico
An Introduction to the NIHR programmes
ADVAC ALUMNI MEETING DURING SAGE
The Irish Forum for Global Health, November 6th 2018 Sheila Garry
‘Data ethics and bio-banking’
Presentation transcript:

GF8 – Vilnius, June 2007 Hugh Whittall Director Nuffield Council on Bioethics Establishing and supporting research ethics infrastructure and networking

Nuffield Council on Bioethics Independent body that examines ethical questions raised by advances in biology and medicine Contributes to policy making and stimulates debate

Themes of presentation 1.Nuffield Reports on research in developing countries 2.Infrastructures for ethical advice and review 3.Support and networking

Report (2002); follow-up Discussion Paper (2005)

Key issues Consent Standards of care Ethical review of research What happens once research is over? Strengthen capacity in developing countries

Consent Purpose is to inform and protect Should fit local context Simple consent forms Innovative ways of providing information Trust of participants is crucial

Standards of care Potentially beneficial research may be prevented by unrealistic requirements Guidelines say local standard of care is often acceptable Discussion with stakeholders in planning stage Longer term sustainability

After the research is over Need mechanism for early discussions Consequences of resource limitations Unrealistic requirements to provide post-trial interventions Not always clear when research is complete Recognise enduring benefits of research

Ethical review RECs to review both ethical and scientific aspects? Need to increase efficiency Local expertise of host REC can be crucial Developing country RECs face serious difficulties Particularly lack of expertise

Bioethics: advisory and ethical review bodies Different models in different countries Model influenced by: –Impact / timing of scientific development –Cultural / political environment –Existing regulatory framework

UK model Government advisory bodies Regulatory authorities Independent advisory bodies Research / clinical ethics committees

Governmental advisory bodies Human Genetics Commission (HGC) Genetics and Insurance Committee (GAIC) Gene Therapy Advisory Committee (GTAC) Animal :Procedures Committee (APC) National Research Ethics Service (NRES)

Regulatory authorities Human Fertilisation and Embryology Authority (HFEA) Human Tissue Authority (HTA) Medicines and Healthcare Products Regulatory Agency (MHRA)

Independent advisory bodies British Medical Association Medical Ethics Committee Medical Royal Colleges Ethics Committees Nuffield Council on Bioethics

Support and networking Formal activities –Global Forum –UNESCO Guides and ABC project –MRC CURE Informal activities –Informal contacts –Sharing of experience Building an ethics community